$P

Yen Mallun sold $364K of P

Yen Mallun sold 4,735 shares of Everpure, Inc. (P) at $76.90 ($0.36M total) on 2026-06-22.

Original reporting
SEC EDGAR · Yen Mallun
Published Jun 24, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:50 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$P
Neutral
low confidence
Mentioned
$P
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PNeutralLow
01

Why it matters

The disclosed open-market sale reduces the director’s direct holdings to 43,281 shares, but the filing provides no operational or financial update for Everpure.

02

Market read

This is primarily a sentiment datapoint from insider selling, with low likelihood of driving price without additional company catalysts.

03

What to watch

Traders should check whether there are multiple consecutive insider sales, changes in ownership concentration, or concurrent company disclosures; this article alone provides only one transaction.

Relevance 4/10Novelty 3/10Timing: filed 2026-06-24, covering sale dated 2026-06-22

Background

The article is an SEC Form 4 insider transaction disclosure for Everpure, Inc. (director Yen Mallun).

Company-level read

Ticker impact

$PNeutralLow confidence
Context

Everpure director Yen Mallun filed a Form 4 for an open-market sale of 4,735 shares at $76.90 on 2026-06-22.

Expected impact

Likely limited near-term impact; any effect would be sentiment-only unless follow-on filings show sustained selling.

Evidence & confidence

Form 4 insider transactions are common and often non-informational; the filing lacks any accompanying company-specific news or performance change.

Market effects

No sector-level implications; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan does not necessarily imply bearish information; sales can be for diversification, taxes, or pre-existing personal liquidity needs.

Key entities

  • Everpure, Inc.

    Company whose director insider sale is disclosed via SEC Form 4.

  • Yen Mallun

    Director who sold 4,735 shares at $76.90 per share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PMedAI 8/10

Everpure (P) Grew Revenue 38% but Free Cash Flow Was Negative. Will the Coming Hyperscaler Ramp Convert Into Cash?

Everpure (NYSE:P) reported Q2 revenue growth of 38% to $1.19B, with product and subscription revenue up 54% and 20% respectively. Operating income rose, but operating cash flow turned negative. The company raised its fiscal 2027 revenue outlook to $5.03-$5.07B, citing strong demand and future hyperscale deployments. However, cash conversion remains a concern due to strategic purchases and higher expenses.

$PHighAI 8/10

Everpure's Q2 Earnings Call Centers on Sustainable Growth

Everpure, Inc. (P) raised its fiscal 2027 guidance, citing resilient demand and market share gains. Q2 revenue was $1.19B, beating estimates. Full-year revenue guidance increased to $5.03-$5.07B, with non-GAAP operating income guidance at $940-$960M. The company also reported a second hyperscale win and strong Data Intelligence customer interest.

$NVDAHighAI 8/10

Futures Jump After Nvidia's Unprecedented 2028 Guidance Stuns Markets

Nvidia (NVDA) surged 7.4% in premarket trading after forecasting 70% revenue growth by 2028, boosting tech sector futures. S&P 500 and Nasdaq futures rose 0.5% and 1.1%, respectively. Other tech stocks like MRVL (+5.2%), INTC (+2%), and AMD (+1%) also gained. Software companies CRWD (+9%), NTNX (+5%), OKTA (+17%), and CRM (+10%) rose on strong forecasts. DG (+13%) gained on better sales, while DLTR (-4%) fell on weak guidance. WEN (-14%) dropped after a report on no private bid plans. Macroecono